$PIRS News Article - Pieris Pharmaceuticals and AstraZeneca Present Multiple Ascending Dose Phase 1b Data for Inhaled IL4-R? Antagonist AZD1402/PRS-060 at the 2019 European Respiratory Society International Congress
https://marketwirenews.com/news-releases/pier...62903.html